Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
GenSight Biologics Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 0/6
GenSight Biologics has a total shareholder equity of €-24.8M and total debt of €21.2M, which brings its debt-to-equity ratio to -85.5%. Its total assets and total liabilities are €15.0M and €39.8M respectively.
Anahtar bilgiler
-85.5%
Borç/özkaynak oranı
€21.24m
Borç
Faiz karşılama oranı | n/a |
Nakit | €6.94m |
Eşitlik | -€24.83m |
Toplam yükümlülükler | €39.82m |
Toplam varlıklar | €14.99m |
Son finansal sağlık güncellemeleri
Health Check: How Prudently Does GenSight Biologics (EPA:SIGHT) Use Debt?
Aug 17Rock star Growth Puts GenSight Biologics (EPA:SIGHT) In A Position To Use Debt
Aug 04Recent updates
Is There An Opportunity With GenSight Biologics S.A.'s (EPA:SIGHT) 30% Undervaluation?
Dec 22Is GenSight Biologics S.A. (EPA:SIGHT) Trading At A 39% Discount?
Sep 20Health Check: How Prudently Does GenSight Biologics (EPA:SIGHT) Use Debt?
Aug 17Rock star Growth Puts GenSight Biologics (EPA:SIGHT) In A Position To Use Debt
Aug 04GenSight Biologics S.A. (EPA:SIGHT) Shares Could Be 27% Below Their Intrinsic Value Estimate
Jun 14GenSight Biologics S.A. (EPA:SIGHT): Is Breakeven Near?
May 10Analysts Expect Breakeven For GenSight Biologics S.A. (EPA:SIGHT) Before Long
Feb 02A Quick Analysis On GenSight Biologics' (EPA:SIGHT) CEO Salary
Dec 09Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: SIGHT has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Uzun Vadeli Yükümlülükler: SIGHT has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: SIGHT has negative shareholder equity, which is a more serious situation than a high debt level.
Borcun Azaltılması: SIGHT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: SIGHT has less than a year of cash runway based on its current free cash flow.
Tahmini Nakit Akışı: SIGHT has less than a year of cash runway if free cash flow continues to grow at historical rates of 0.9% each year.